|
|
|
|
C-SALVAGE: GRAZOPREVIR (GZR; MK-5172), ELBASVIR (EBR; MK-8742) AND RIBAVIRIN (RBV) FOR CHRONIC HCV-GENOTYPE 1 (GT1) INFECTION AFTER FAILURE OF DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
|
|
|
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Download the PDF here
|
|
|
|
|
|
|